| Inhibition of ACE2‐Spike Interaction by an ACE2 Binder Suppresses SARS‐CoV‐2 Entry YH Shin, K Jeong, J Lee, HJ Lee, J Yim, J Kim, S Kim, SB Park Angewandte Chemie 134 (11), e202115695, 2022 | 35 | 2022 |
| Targeted protein upregulation of STING for boosting the efficacy of immunotherapy W Cho, S Won, Y Choi, S Yi, JB Park, JG Park, CE Kim, C Narayana, ... Angewandte Chemie International Edition 62 (18), e202300978, 2023 | 16 | 2023 |
| Improved Th17 selectivity of α-galactosylceramide via noncovalent interactions with diether moiety YS Hwang, J Yim, H Song, SB Park ACS Medicinal Chemistry Letters 10 (5), 720-725, 2019 | 9 | 2019 |
| Phenotype-based screening rediscovered benzopyran-embedded microtubule inhibitors as anti-neuroinflammatory agents by modulating the tubulin–p65 interaction J Yim, J Lee, S Yi, JY Koo, S Oh, H Park, SS Kim, MA Bae, J Park, SB Park Experimental & Molecular Medicine 54 (12), 2200-2209, 2022 | 4 | 2022 |
| Label-Free Target Identification Reveals the Anticancer Mechanism of a Rhenium Isonitrile Complex J Yim, SB Park Frontiers in Chemistry 10, 850638, 2022 | 4 | 2022 |
| Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation J Yim, J Park, G Kim, A Jo, M Koh, J Park ChemMedChem, e202400326, 0 | 3 | |
| Inflachromene ameliorates Parkinson's disease by targeting Nrf2-binding Keap1 J Yim, YS Hwang, JJ Lee, JH Kim, JY Baek, J Jeong, YI Choi, BK Jin, ... Chemical Science 15 (10), 3588-3595, 2024 | 1 | 2024 |
| SB1703 has therapeutic effect on syngeneic mouse model as an immune modulator in TME HY Kim, HJ Kim, JH Jung, SY Jo, JH Kim, W Cho, M Kim, J Yim, SB Park Cancer Research 79 (13_Supplement), 2816-2816, 2019 | | 2019 |
